Published Paper Details:

Candida auris is a newly recognized yeast pathogen that was first identified in 2009 in Japan. Since then, it has spread globally and is now a cause of serious infections, particularly in healthcare settings. These infections often lead to high death rates and pose challenges due to antifungal resistance. The yeast can survive in the environment, colonize patients, and avoid standard identification methods, making detection and control difficult. This review compiles current information on the epidemiology, microbiology, pathogenesis, diagnostics, and mechanisms of antifungal susceptibility and resistance of C. auris. It also looks at strategies for preventing and controlling infections. The discussion points out significant gaps in knowledge and urges improvements in surveillance, diagnostics, new treatments, and stricter infection control measures. In conclusion, C. auris is a major emerging fungal threat with many unresolved issues that need immediate attention.